Saferx Pharmaceuticals, Inc

SafeRx Pharmaceuticals, Inc., based in Lenox, MA, is a development-stage drug company focused on creating innovative medications aimed at reducing the risk of overdose, particularly in the context of opioid and alcohol interactions. Their proprietary Alcohol Resistant Opioid (ARO) technology seeks to address a critical aspect of the U.S. opioid crisis by preventing the dangerous combination of opioids and alcohol, which is linked to a significant number of overdose deaths.

With a mission to save tens of thousands of lives, SafeRx Pharmaceuticals is pursuing FDA approval for its ARO platform, which is designed to become a new standard of care for at-risk patients. The company has recently launched an equity crowdfunding campaign to garner support for its initiatives in combating the opioid crisis.

Generated from the website